Transplantation
Astellas Europe is a major player in the transplantation community. Its products are recognised worldwide in the prevention of organ rejection following kidney, liver, and heart transplantation.
Astellas Europe remains focused on investing in its pipeline of potential future immunosuppressant therapies. Through sustained investment in almost 100 European clinical studies, we are continually striving to advance transplant care by developing both new treatment regimens and innovative therapies that target specific pathways.
We are also proud to be able to support many patient organisations, helping to offer hope for the future.
